Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP1R14BP4 is a processed pseudogene of the protein phosphatase 1 regulatory inhibitor subunit 14B gene family[3][5][7]. As a pseudogene, it does not encode a functional protein and contains sequence similarity to the active PPP1R14B gene, which normally functions as an inhibitor of protein phosphatase 1, an enzyme involved in numerous cellular processes. Pseudogenes like PPP1R14BP4 generally arise through retrotransposition, lack coding potential due to disruptive mutations, and are typically transcriptionally silent. However, while some processed pseudogenes may be transcribed or have regulatory roles at the RNA level, there is no evidence that PPP1R14BP4 serves as a therapeutic target, nor is it known to interact with drugs or act as a biomarker[2][3][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on protein phosphatase 1 regulatory inhibitor subunit 14B pseudogene 4 (PPP1R14BP4).